{"gene":"GUCY2D","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1995,"finding":"RetGC-1 (GUCY2D) is a photoreceptor-specific membrane guanylyl cyclase whose recombinant form expressed in HEK293 cells has membrane GC activity that is stimulated by the activator p24 (GCAP) and inhibited by Ca2+ with an EC50 of 50-100 nM, establishing its core enzymatic properties and Ca2+ sensitivity.","method":"Recombinant expression in HEK293 cells, membrane GC activity assay, Ca2+ inhibition assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of enzymatic activity with quantitative Ca2+ sensitivity measurement","pmids":["7777544"],"is_preprint":false},{"year":1998,"finding":"Dominant cone-rod dystrophy (CORD6) is caused by missense mutations (E837D, R838C) in GUCY2D specifically in the dimerization domain, establishing GUCY2D as a causal gene for autosomal dominant retinal degeneration.","method":"Mutation screening by sequencing of GUCY2D in affected families; segregation analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic linkage plus mutation identification replicated across multiple families and labs","pmids":["9618177"],"is_preprint":false},{"year":1999,"finding":"The F514S mutation in ROS-GC1 (GUCY2D), linked to Leber congenital amaurosis (LCA1), severely damages intrinsic cyclase activity and inactivates the GCAP1-regulated CRM1 Ca2+ switch but does not affect the CRM2 switch, demonstrating domain-specific functional dissection of the two Ca2+ regulatory modules.","method":"In vitro mutagenesis, cGMP synthesis assay, Ca2+ sensitivity measurement in COS cell-expressed mutants","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with enzymatic assay and domain-specific functional readout","pmids":["9888789"],"is_preprint":false},{"year":1999,"finding":"The R838C substitution in the RetGC-1 dimerization domain reduces overall catalytic ability, dramatically reduces stimulation by GCAP-2, increases apparent affinity for GCAP-1, and alters Ca2+ sensitivity of the GCAP-1 response, allowing mutant to be stimulated by GCAP-1 at higher Ca2+ concentrations than wild type — demonstrating a gain-of-function dominant mechanism.","method":"In vitro mutagenesis, cGMP synthesis assay, GCAP activation assays, Ca2+ sensitivity measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and multiple orthogonal assays","pmids":["10430891"],"is_preprint":false},{"year":1999,"finding":"Two short regulatory regions (M445-L456 and L503-I522) in the juxtamembrane domain (JMD) of ROS-GC1 are critical for activation by GCAP-1, as identified by peptide competition and mutagenesis studies.","method":"Peptide competition assays, site-directed mutagenesis, GC activity assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis plus peptide competition with direct enzymatic readout","pmids":["10571055"],"is_preprint":false},{"year":1999,"finding":"Neurocalcin is identified as a novel Ca2+-dependent activator of ROS-GC1 (GUCY2D), stimulating it in a dose-dependent fashion with EC50 ~20 µM Ca2+; the neurocalcin-regulated domain (CRM4) maps to the C-terminal segment (aa 731-1054) but is distinct from the CRM2 domain regulated by CD-GCAP.","method":"Recombinant protein assay, deletion mapping, GC activity assay, domain reconstruction","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with domain mapping via deletion mutants","pmids":["10504230"],"is_preprint":false},{"year":1998,"finding":"CD-GCAP differentially activates ROS-GC1 and ROS-GC2; the CD-GCAP-regulated stimulatory switch resides within amino acids 736-1053 of the cyclase, established by deletion, hybrid, and reconstruction expression studies.","method":"Deletion mutants, hybrid cyclase construction, heterologous expression, GC activity assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — domain mapping by multiple mutant constructs with direct enzymatic readout","pmids":["9439621"],"is_preprint":false},{"year":2001,"finding":"cGMP synthesis by RetGC-1 requires dimerization, and an intact alpha-helical coiled-coil structure in the dimerization domain is required for catalytic function; Arg838 within the dimerization domain establishes Ca2+ sensitivity of RetGC-1 by determining coiled-coil interaction strength. Arg838 substitutions dominantly enhance cGMP synthesis even at high Ca2+ and disrupt a salt bridge network as shown by molecular dynamics.","method":"In vitro mutagenesis, cGMP synthesis assay, Ca2+ sensitivity assay, molecular dynamics simulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution, mutagenesis, and MD simulation providing mechanistic structural explanation","pmids":["11306565"],"is_preprint":false},{"year":2001,"finding":"Complete abolition of retGC-1 catalytic activity (either by truncating mutations or by missense mutations in the catalytic domain) consistently leads to LCA; catalytic domain missense mutations abolish GTP-to-cGMP conversion in COS7 cells, while extracellular domain missense mutations mostly retain normal catalytic activity.","method":"In vitro mutagenesis, expression in COS7 cells, cGMP synthesis assay","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 — systematic in vitro functional analysis of 9 LCA-linked mutations with enzymatic assay","pmids":["11328726"],"is_preprint":false},{"year":2004,"finding":"The Ca2+ sensitivity of RetGC-1 regulation by GCAP-1 is determined by both the affinity of GCAP-1 for Ca2+ and the relative affinities of the Ca2+-free vs. Ca2+-bound GCAP-1 for RetGC-1. The R838S CORD6 mutation increases the Ca2+ concentration required for half-maximal inhibition from 0.27 to 0.61 µM, primarily by changing the relative affinity of the mutant cyclase for Ca2+-free vs. Ca2+-loaded GCAP-1.","method":"Quantitative kinetic binding assay, Ca2+ sensitivity measurements, Mg2+-dependence analysis of recombinant RetGC-1","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro kinetic analysis with mutagenesis","pmids":["15504042"],"is_preprint":false},{"year":2004,"finding":"LCA-linked catalytic domain mutations P858S and L954P in RetGC-1 severely impair basal and GCAP-1/GCAP-2-stimulated catalytic activity and act as dominant negative proteins when co-expressed with wild-type allele, reducing wild-type RetGC-1 activity. Extracellular domain mutations C105Y and L325P reduce GCAP-stimulated but not basal activity.","method":"In vitro mutagenesis, expression in HEK-293 cells, cGMP synthesis assay, co-expression dominant-negative assay","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with enzymatic activity and dominant-negative co-expression assay","pmids":["15123990"],"is_preprint":false},{"year":2011,"finding":"RD3 protein is a high-affinity allosteric inhibitor of RetGC1 (GUCY2D), suppressing basal and GCAP-stimulated RetGC activity at submicromolar concentrations in a noncompetitive manner without significantly changing Ca2+ sensitivity; LCA12-associated RD3 truncation mutant fails to suppress RetGC1/GCAP complex, and several RD3 disease mutations decrease RD3 affinity for RetGC1.","method":"Recombinant protein expression in HEK293 cells, GC activity assay, mutagenesis, binding assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of allosteric inhibition with mutagenesis and binding characterization","pmids":["21928830"],"is_preprint":false},{"year":2012,"finding":"Ca2+-sensor protein S100B coexists with ROS-GC1 (GUCY2D) in cones but not rods of the murine retina, upregulates ROS-GC1 activity with K1/2 for Ca2+ >500 nM, and modulates neural signal transmission to cone ON-bipolar cells, as demonstrated by gene deletion models and single-cell recordings.","method":"Gene deletion mouse models, biochemistry, immunohistochemistry, ERG, single-cell recordings","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in intact retina including KO mouse, ERG, and single-cell recordings","pmids":["22508049"],"is_preprint":false},{"year":2018,"finding":"The R838S mutation in RetGC1 causes CORD6 by deregulating Ca2+-sensitive feedback of phototransduction via GCAPs: transgenic mice expressing R838S RetGC1 show elevated dark cGMP, increased dark current, and altered rod photoresponses; photoreceptor degeneration is prevented in GCAP1,2-/- double knockout background, establishing GCAPs-mediated Ca2+ feedback as the primary trigger for degeneration.","method":"Transgenic mouse model, single-cell electrophysiology, ERG, genetic epistasis with GCAP KO","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — transgenic + genetic epistasis with physiological recordings, replicated across two mouse lines","pmids":["29440533"],"is_preprint":false},{"year":2018,"finding":"Multiple GUCY2D mutations in the dimerization domain (E841K, K846N) shift Ca2+-sensitive regulation by GCAPs; the catalytic domain mutant P873R causes loss of function; and V902L causes a >20-fold increase in GC activity (constitutively active), showing distinct gain- and loss-of-function mechanisms depending on mutation location.","method":"Expression in HEK293 cells, GC activity assay, Ca2+ sensitivity assay, RD3 interaction assay","journal":"Frontiers in molecular neuroscience","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic characterization of multiple mutants with Ca2+ regulation analysis","pmids":["30319355"],"is_preprint":false},{"year":2020,"finding":"CSNB-linked mutations R666W, R761W, and L911F disable RetGC1 activation by GCAP1, -2, and -3; R666W and R761W additionally compromise GCAP1 binding in HEK293 cells; G982VfsX39 and L911F retain GCAP1 binding but fail to bind RD3; R768W fails to bind either GCAP1 or RD3. The CORD6 mutation R838S dominantly shifts Ca2+ sensitivity in the RetGC1 heterodimer (WT+R838S), requiring ~6-fold higher Ca2+ to decelerate cyclase compared to WT homodimer.","method":"In vitro mutagenesis, expression in HEK293 cells, GC activity assay, Ca2+ sensitivity measurement, co-immunoprecipitation binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic in vitro biochemical characterization with multiple mutants across disease classes","pmids":["33109612"],"is_preprint":false},{"year":1998,"finding":"ROS-GC1 (GUCY2D) gene is composed of 20 exons and 19 introns spanning 18.5 kb, and the gene is induced by phorbol ester (protein kinase C activator), suggesting PKC-mediated transcriptional regulation of ROS-GC1 in photoreceptors.","method":"Gene structural analysis, luciferase reporter assay in COS cells, phorbol ester treatment","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — gene structure determination plus reporter assay for PKC regulation","pmids":["9879655"],"is_preprint":false},{"year":2004,"finding":"S100B binds to domain amino acids Gly962-Asn981 of ROS-GC1 and signals through transduction domain aa Ile1030-Gln1041 to activate ROS-GC1 in gustatory epithelium, generating cGMP as a second messenger in gustatory transduction.","method":"Peptide competition, domain mutagenesis, GC activity assay, functional characterization in bovine gustatory epithelium","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 — domain mapping by peptide competition and mutagenesis but in a non-retinal context","pmids":["15556616"],"is_preprint":false},{"year":2016,"finding":"Bicarbonate (generated from CO2 via carbonic anhydrase) directly targets the core catalytic domain of ROS-GC1 and activates it independently of Ca2+, synergizing with GCAP- and S100B-mediated Ca2+-dependent pathways; GCAP1 and GCAP2 signal through distinct domain-specific modules of ROS-GC1.","method":"Recombinant reconstitution, GC activity assay with bicarbonate, mutagenesis of LCA1-linked F514S mutant","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with direct enzymatic assay, but single lab","pmids":["26858600"],"is_preprint":false},{"year":2013,"finding":"Expression of mutant human RETGC-1 (E837D/R838S) in zebrafish cone photoreceptors under the cone-specific gnat2 promoter causes aberrant cone morphology, reduced cone density, and reduced rod outer segment labeling, demonstrating that CORD6-linked GUCY2D mutations directly cause photoreceptor structural pathology in vivo.","method":"Transgenic zebrafish expression, fluorescent microscopy of retinal morphology, optokinetic response assay","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic in vivo model with retinal morphology and functional readout","pmids":["23328348"],"is_preprint":false},{"year":2016,"finding":"The S248W GUCY2D mutation fails to restore rod and cone ERG function and shows marginal protein expression in photoreceptor outer segments in AAV-treated Gucy2e knockout mouse retinas, despite normal enzymatic activity in HEK293 cells, indicating that this mutation causes LCA1 by impairing protein expression, processing, or transport rather than catalytic activity.","method":"AAV-mediated expression in Gucy2e KO mouse retinas, ERG, immunofluorescence, immunoblot, GC activity assay","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo AAV expression in KO mouse with multiple readouts contrasted with in vitro data","pmids":["27881908"],"is_preprint":false},{"year":2026,"finding":"An engineered protein inhibitor of retinal guanylyl cyclase (PIGCY) expressed in transgenic GUCY2D adCORD (R838S) mice suppresses aberrant cGMP production, prevents rod photoreceptor degeneration (70% of nuclei preserved vs. 20% in R838S alone at 6 months), and maintains functional light sensitivity, demonstrating that reducing cGMP synthesis is sufficient to rescue degenerating GUCY2D adCORD rods.","method":"Transgenic mouse model, ERG, single-photon response recording, photoreceptor nuclei counting, GC activity measurement","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo genetic rescue with functional and structural endpoints, multiple orthogonal readouts","pmids":["42045071"],"is_preprint":false},{"year":2021,"finding":"Gucy2d is selectively expressed in dynorphin-lineage inhibitory neurons in laminae I-III of the adult mouse spinal dorsal horn but not in the brain or DRG; Gucy2d knockout mice show no altered responses to itch or pain, indicating the protein is dispensable for these sensory functions in spinal cord.","method":"In situ hybridization, Gucy2d knockout mouse behavioral assays (pain, itch)","journal":"Pain reports","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with defined behavioral readout and localization by ISH, but non-retinal context","pmids":["34296052"],"is_preprint":false}],"current_model":"GUCY2D encodes retinal membrane guanylyl cyclase 1 (RetGC1/ROS-GC1), a photoreceptor-specific enzyme that synthesizes cGMP from GTP; its catalytic activity requires homodimerization via a coiled-coil dimerization domain, is stimulated at low Ca2+ by GCAP1 and GCAP2 binding to distinct juxtamembrane and C-terminal regulatory modules, is inhibited at high Ca2+ through the same GCAPs, is additionally modulated by neurocalcin, S100B, CD-GCAP, bicarbonate, and by RD3 protein (a high-affinity allosteric inhibitor); dominant CORD6-causing mutations at Arg838 in the dimerization domain shift Ca2+ sensitivity of GCAP-mediated regulation, causing constitutive cGMP overproduction in the dark that elevates free Ca2+ and triggers photoreceptor degeneration through a phototransduction feedback mechanism, while recessive LCA1-causing mutations abolish catalytic activity or impair GCAP binding/RD3 binding, leading to insufficient cGMP synthesis and failure of phototransduction recovery."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing RetGC1 as a Ca²⁺-sensitive guanylyl cyclase answered the question of which enzyme regenerates cGMP in photoreceptors and how phototransduction feedback operates at the enzymatic level.","evidence":"Recombinant RetGC-1 expressed in HEK293 cells showed membrane GC activity stimulated by GCAP and inhibited by Ca²⁺ with EC50 ~50–100 nM","pmids":["7777544"],"confidence":"High","gaps":["No structural model of the cyclase","Stoichiometry and binding mode of GCAP interaction unknown","In vivo validation of Ca²⁺ sensitivity parameters not yet performed"]},{"year":1998,"claim":"Identification of CORD6-causing mutations (E837D, R838C) in the dimerization domain and mapping of CD-GCAP and GCAP1 regulatory regions defined both the disease relevance and modular regulatory architecture of RetGC1.","evidence":"Genetic linkage and sequencing in affected families identified dimerization-domain mutations; deletion/hybrid cyclase constructs mapped CD-GCAP signaling to aa 736–1053 and GCAP1 regulation to juxtamembrane residues M445–L456 and L503–I522","pmids":["9618177","9439621","10571055"],"confidence":"High","gaps":["Mechanism by which dimerization domain mutations cause dominant disease not yet biochemically resolved","Relationship between GCAP1 and CD-GCAP regulatory modules unclear"]},{"year":1999,"claim":"In vitro reconstitution of CORD6 (R838C) and LCA1 (F514S) mutations revealed that disease arises through fundamentally different mechanisms — gain-of-function Ca²⁺-sensitivity shift versus loss of catalytic activity — answering how the same gene causes dominant and recessive disease.","evidence":"R838C increased apparent GCAP-1 affinity and allowed cyclase stimulation at elevated Ca²⁺; F514S abolished intrinsic cyclase activity and CRM1 but not CRM2 regulation; neurocalcin identified as a distinct Ca²⁺-dependent activator acting through CRM4","pmids":["10430891","9888789","10504230"],"confidence":"High","gaps":["In vivo confirmation of gain-of-function mechanism not yet obtained","Physiological relevance of neurocalcin regulation to photoreceptor function unclear"]},{"year":2001,"claim":"Demonstrating that RetGC1 functions as a dimer whose coiled-coil integrity determines both catalytic competence and Ca²⁺ sensitivity established the structural basis for Arg838 dominant mutations.","evidence":"Mutagenesis and molecular dynamics showed that Arg838 substitutions disrupt a salt-bridge network in the dimerization domain, enabling cGMP synthesis even at high Ca²⁺; catalytic-domain LCA mutations abolish GTP-to-cGMP conversion","pmids":["11306565","11328726"],"confidence":"High","gaps":["No crystal or cryo-EM structure of the dimerization domain","How dimer interface perturbation propagates to catalytic domain activation unknown"]},{"year":2004,"claim":"Quantitative kinetic analysis revealed that CORD6 mutations shift Ca²⁺ sensitivity by altering the relative affinity of Ca²⁺-free versus Ca²⁺-bound GCAP1 for RetGC1, and that some LCA mutations act as dominant negatives through heterodimer poisoning.","evidence":"R838S raised the Ca²⁺ IC50 from 0.27 to 0.61 µM by changing GCAP1 binding equilibria; P858S and L954P reduced wild-type activity in co-expression assays; S100B mapped to Gly962–Asn981 in gustatory epithelium","pmids":["15504042","15123990","15556616"],"confidence":"High","gaps":["Dominant-negative mechanism not validated in photoreceptor models","Physiological relevance of S100B regulation in taste versus retina unclear"]},{"year":2011,"claim":"Identification of RD3 as a high-affinity allosteric inhibitor of RetGC1 revealed a second layer of cyclase regulation beyond GCAPs and explained LCA12 pathogenesis.","evidence":"Recombinant RD3 suppressed basal and GCAP-stimulated RetGC1 activity at submicromolar concentrations noncompetitively; LCA12 truncation mutant lost inhibitory function","pmids":["21928830"],"confidence":"High","gaps":["RD3 binding site on RetGC1 not mapped","In vivo dynamics of RD3-RetGC1 interaction in outer segments unknown"]},{"year":2016,"claim":"Discovery that bicarbonate directly activates the RetGC1 catalytic domain independently of Ca²⁺ added a metabolic regulatory input to phototransduction, and in vivo testing showed that the S248W LCA1 mutation impairs protein trafficking rather than catalysis.","evidence":"Bicarbonate activated recombinant RetGC1 synergistically with GCAP pathways; S248W showed normal HEK293 activity but failed to reach outer segments or restore ERG in AAV-treated Gucy2e KO mice","pmids":["26858600","27881908"],"confidence":"Medium","gaps":["Bicarbonate regulation not confirmed in intact photoreceptors","Trafficking mechanism of RetGC1 to outer segments not elucidated"]},{"year":2018,"claim":"Genetic epistasis in transgenic mice proved that CORD6 photoreceptor degeneration is driven through GCAP-mediated Ca²⁺ feedback rather than cyclase-intrinsic toxicity, resolving the in vivo pathogenic mechanism.","evidence":"R838S transgenic mice showed elevated dark cGMP and degeneration prevented in GCAP1,2 double-knockout background; additional dimerization-domain mutants (E841K, K846N) confirmed shifted Ca²⁺ regulation while V902L showed constitutive activation","pmids":["29440533","30319355"],"confidence":"High","gaps":["Cone-specific degeneration mechanism not fully characterized in vivo","Whether constitutively active mutants also require GCAPs for toxicity unknown"]},{"year":2020,"claim":"Systematic analysis of CSNB-linked mutations showed that loss of GCAP binding and/or RD3 binding represent separable disease mechanisms, and that R838S dominantly shifts Ca²⁺ sensitivity even in WT/mutant heterodimers.","evidence":"R666W and R761W lost GCAP1 binding; G982VfsX39 and L911F lost RD3 binding; WT+R838S heterodimer required ~6-fold more Ca²⁺ for deceleration versus WT homodimer","pmids":["33109612"],"confidence":"High","gaps":["Heterodimer structure not resolved","Relative abundance of WT vs mutant allele in heterozygous photoreceptors unknown"]},{"year":2026,"claim":"Therapeutic rescue demonstrated that reducing aberrant cGMP production is sufficient to prevent CORD6 degeneration, validating cyclase output as the druggable node in dominant GUCY2D disease.","evidence":"Engineered protein inhibitor (PIGCY) in R838S transgenic mice preserved 70% photoreceptor nuclei at 6 months and maintained light sensitivity by ERG and single-photon recordings","pmids":["42045071"],"confidence":"High","gaps":["Long-term durability of PIGCY-mediated rescue not established","Cone rescue not demonstrated","Optimal level of cyclase inhibition for clinical translation unknown"]},{"year":null,"claim":"High-resolution structural models of full-length RetGC1 dimers, the precise binding interfaces for GCAPs and RD3, and the mechanism by which bicarbonate and metabolic signals integrate with Ca²⁺-dependent regulation in intact photoreceptors remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or crystal structure of RetGC1 homodimer","GCAP and RD3 binding interfaces not structurally resolved","Cone-specific regulatory mechanisms poorly characterized in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0009975","term_label":"cyclase activity","supporting_discovery_ids":[0,2,7,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,20]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,13,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,9,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,8,13]}],"complexes":["RetGC1 homodimer"],"partners":["GUCA1A","GUCA1B","RD3","S100B","VILIP3"],"other_free_text":[]},"mechanistic_narrative":"GUCY2D encodes retinal guanylyl cyclase 1 (RetGC1/ROS-GC1), a photoreceptor-specific membrane guanylyl cyclase that synthesizes cGMP from GTP and is essential for phototransduction recovery. Its catalytic activity requires homodimerization via an α-helical coiled-coil dimerization domain and is stimulated at low Ca²⁺ by guanylyl cyclase-activating proteins (GCAP1 and GCAP2) binding to distinct juxtamembrane and C-terminal regulatory modules, with additional modulation by neurocalcin, S100B, RD3 (a high-affinity allosteric inhibitor), and bicarbonate [PMID:7777544, PMID:10504230, PMID:21928830, PMID:26858600]. Recessive loss-of-function mutations in the catalytic domain cause Leber congenital amaurosis type 1 (LCA1) by abolishing cGMP synthesis, whereas dominant gain-of-function mutations at Arg838 in the dimerization domain cause cone-rod dystrophy (CORD6) by shifting GCAP-mediated Ca²⁺-sensitive feedback so that cGMP overproduction persists at elevated Ca²⁺, triggering photoreceptor degeneration through a GCAP-dependent mechanism [PMID:9618177, PMID:11328726, PMID:29440533, PMID:33109612]. Suppression of aberrant cGMP production by an engineered inhibitor rescues photoreceptor degeneration in a CORD6 mouse model, confirming that dysregulated cyclase output is the proximal cause of disease [PMID:42045071]."},"prefetch_data":{"uniprot":{"accession":"Q02846","full_name":"Retinal guanylyl cyclase 1","aliases":["CG-E","Guanylate cyclase 2D, retinal","Rod outer segment membrane guanylate cyclase","ROS-GC"],"length_aa":1103,"mass_kda":120.1,"function":"Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment (PubMed:15123990, PubMed:21928830, PubMed:26100624, PubMed:30319355, PubMed:9600905). May also participate in the trafficking of membrane-associated proteins to the photoreceptor outer segment membrane (By similarity)","subcellular_location":"Photoreceptor outer segment membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q02846/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GUCY2D","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GUCY2D","total_profiled":1310},"omim":[{"mim_id":"618555","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I","url":"https://www.omim.org/entry/618555"},{"mim_id":"613826","title":"LEBER CONGENITAL AMAUROSIS 6; LCA6","url":"https://www.omim.org/entry/613826"},{"mim_id":"613776","title":"CHROMOSOME 17p13.1 DELETION SYNDROME","url":"https://www.omim.org/entry/613776"},{"mim_id":"611408","title":"LEBERILIN LCA5; LCA5","url":"https://www.omim.org/entry/611408"},{"mim_id":"610612","title":"LEBER CONGENITAL AMAUROSIS 12; LCA12","url":"https://www.omim.org/entry/610612"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":31.7}],"url":"https://www.proteinatlas.org/search/GUCY2D"},"hgnc":{"alias_symbol":["retGC","RETGC-1","ROS-GC1","CYGD","LCA1","ROS-GC"],"prev_symbol":["CORD6","LCA","GUC2D","GUC1A4"]},"alphafold":{"accession":"Q02846","domains":[{"cath_id":"3.40.50.2300","chopping":"51-166_345-392","consensus_level":"medium","plddt":87.7297,"start":51,"end":392},{"cath_id":"3.40.50.2300","chopping":"169-282_285-319_398-456","consensus_level":"medium","plddt":88.1724,"start":169,"end":456},{"cath_id":"1.10.510.10","chopping":"553-815","consensus_level":"medium","plddt":87.3505,"start":553,"end":815},{"cath_id":"3.30.70.1230","chopping":"875-1096","consensus_level":"high","plddt":86.7786,"start":875,"end":1096}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02846","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q02846-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q02846-F1-predicted_aligned_error_v6.png","plddt_mean":82.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GUCY2D","jax_strain_url":"https://www.jax.org/strain/search?query=GUCY2D"},"sequence":{"accession":"Q02846","fasta_url":"https://rest.uniprot.org/uniprotkb/Q02846.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q02846/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02846"}},"corpus_meta":[{"pmid":"7777544","id":"PMC_7777544","title":"Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7777544","citation_count":229,"is_preprint":false},{"pmid":"9618177","id":"PMC_9618177","title":"Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9618177","citation_count":217,"is_preprint":false},{"pmid":"15608217","id":"PMC_15608217","title":"CYGD: the Comprehensive Yeast Genome Database.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15608217","citation_count":212,"is_preprint":false},{"pmid":"10430891","id":"PMC_10430891","title":"Biochemical analysis of a dimerization domain mutation in RetGC-1 associated with dominant cone-rod dystrophy.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10430891","citation_count":100,"is_preprint":false},{"pmid":"11306565","id":"PMC_11306565","title":"Interactions within the coiled-coil domain of RetGC-1 guanylyl cyclase are optimized for regulation rather than for high affinity.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11306565","citation_count":85,"is_preprint":false},{"pmid":"10647719","id":"PMC_10647719","title":"Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase.","date":"2000","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/10647719","citation_count":81,"is_preprint":false},{"pmid":"16272259","id":"PMC_16272259","title":"Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16272259","citation_count":76,"is_preprint":false},{"pmid":"9888789","id":"PMC_9888789","title":"Functional consequences of a rod outer segment membrane guanylate cyclase (ROS-GC1) gene mutation linked with Leber's congenital amaurosis.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9888789","citation_count":73,"is_preprint":false},{"pmid":"29061346","id":"PMC_29061346","title":"Genotype-functional-phenotype correlations in photoreceptor guanylate cyclase (GC-E) encoded by GUCY2D.","date":"2017","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/29061346","citation_count":71,"is_preprint":false},{"pmid":"30358434","id":"PMC_30358434","title":"Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque.","date":"2018","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30358434","citation_count":68,"is_preprint":false},{"pmid":"10571055","id":"PMC_10571055","title":"Regions in vertebrate photoreceptor guanylyl cyclase ROS-GC1 involved in Ca(2+)-dependent regulation by guanylyl cyclase-activating protein GCAP-1.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10571055","citation_count":67,"is_preprint":false},{"pmid":"18487367","id":"PMC_18487367","title":"Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18487367","citation_count":66,"is_preprint":false},{"pmid":"17996202","id":"PMC_17996202","title":"The yeast acylglycerol acyltransferase LCA1 is a key component of Lands cycle for phosphatidylcholine turnover.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17996202","citation_count":61,"is_preprint":false},{"pmid":"31704230","id":"PMC_31704230","title":"GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History Study in Preparation for Trials of Novel Therapies.","date":"2019","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31704230","citation_count":50,"is_preprint":false},{"pmid":"15504042","id":"PMC_15504042","title":"Factors that determine Ca2+ sensitivity of photoreceptor guanylyl cyclase. Kinetic analysis of the interaction between the Ca2+-bound and the Ca2+-free guanylyl cyclase activating proteins (GCAPs) and recombinant photoreceptor guanylyl cyclase 1 (RetGC-1).","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15504042","citation_count":47,"is_preprint":false},{"pmid":"8641699","id":"PMC_8641699","title":"Evidence of genetic heterogeneity of Leber's congenital amaurosis (LCA) and mapping of LCA1 to chromosome 17p13.","date":"1996","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8641699","citation_count":46,"is_preprint":false},{"pmid":"11328726","id":"PMC_11328726","title":"Complete abolition of the retinal-specific guanylyl cyclase (retGC-1) catalytic ability consistently leads to leber congenital amaurosis (LCA).","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11328726","citation_count":43,"is_preprint":false},{"pmid":"21928830","id":"PMC_21928830","title":"Retinal degeneration 3 (RD3) protein inhibits catalytic activity of retinal membrane guanylyl cyclase (RetGC) and its stimulation by activating proteins.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21928830","citation_count":42,"is_preprint":false},{"pmid":"10504230","id":"PMC_10504230","title":"A second calcium regulator of rod outer segment membrane guanylate cyclase, ROS-GC1: neurocalcin.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10504230","citation_count":41,"is_preprint":false},{"pmid":"33997691","id":"PMC_33997691","title":"Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/33997691","citation_count":38,"is_preprint":false},{"pmid":"12623820","id":"PMC_12623820","title":"Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis.","date":"2003","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/12623820","citation_count":37,"is_preprint":false},{"pmid":"15123990","id":"PMC_15123990","title":"Functional analyses of mutant recessive GUCY2D alleles identified in Leber congenital amaurosis patients: protein domain comparisons and dominant negative effects.","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15123990","citation_count":35,"is_preprint":false},{"pmid":"21647387","id":"PMC_21647387","title":"Bicistronic lentiviruses containing a viral 2A cleavage sequence reliably co-express two proteins and restore vision to an animal model of LCA1.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21647387","citation_count":35,"is_preprint":false},{"pmid":"28212877","id":"PMC_28212877","title":"Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations.","date":"2017","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/28212877","citation_count":32,"is_preprint":false},{"pmid":"12552567","id":"PMC_12552567","title":"Identification of GUCY2D gene mutations in CORD5 families and evidence of incomplete penetrance.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12552567","citation_count":31,"is_preprint":false},{"pmid":"12365911","id":"PMC_12365911","title":"Electroretinographic abnormalities in parents of patients with Leber congenital amaurosis who have heterozygous GUCY2D mutations.","date":"2002","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/12365911","citation_count":28,"is_preprint":false},{"pmid":"25515582","id":"PMC_25515582","title":"Whole exome sequencing reveals GUCY2D as a major gene associated with cone and cone-rod dystrophy in Israel.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25515582","citation_count":27,"is_preprint":false},{"pmid":"39244273","id":"PMC_39244273","title":"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study.","date":"2024","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/39244273","citation_count":25,"is_preprint":false},{"pmid":"22378290","id":"PMC_22378290","title":"Gucy2f zebrafish knockdown--a model for Gucy2d-related leber congenital amaurosis.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22378290","citation_count":25,"is_preprint":false},{"pmid":"29559409","id":"PMC_29559409","title":"Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D.","date":"2018","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/29559409","citation_count":25,"is_preprint":false},{"pmid":"29440533","id":"PMC_29440533","title":"GUCY2D Cone-Rod Dystrophy-6 Is a \"Phototransduction Disease\" Triggered by Abnormal Calcium Feedback on Retinal Membrane Guanylyl Cyclase 1.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29440533","citation_count":25,"is_preprint":false},{"pmid":"17200655","id":"PMC_17200655","title":"Novel triple missense mutations of GUCY2D gene in Japanese family with cone-rod dystrophy: possible use of genotyping microarray.","date":"2006","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17200655","citation_count":24,"is_preprint":false},{"pmid":"9439621","id":"PMC_9439621","title":"Differential activation of rod outer segment membrane guanylate cyclases, ROS-GC1 and ROS-GC2, by CD-GCAP and identification of the signaling domain.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9439621","citation_count":24,"is_preprint":false},{"pmid":"15111605","id":"PMC_15111605","title":"Novel complex GUCY2D mutation in Japanese family with cone-rod dystrophy.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15111605","citation_count":23,"is_preprint":false},{"pmid":"22194653","id":"PMC_22194653","title":"A recurrent mutation in GUCY2D associated with autosomal dominant cone dystrophy in a Chinese family.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/22194653","citation_count":23,"is_preprint":false},{"pmid":"17041576","id":"PMC_17041576","title":"Phenotype of autosomal dominant cone-rod dystrophy due to the R838C mutation of the GUCY2D gene encoding retinal guanylate cyclase-1.","date":"2006","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17041576","citation_count":22,"is_preprint":false},{"pmid":"25256176","id":"PMC_25256176","title":"Leber congenital amaurosis caused by mutations in GUCY2D.","date":"2014","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25256176","citation_count":21,"is_preprint":false},{"pmid":"20517349","id":"PMC_20517349","title":"A novel recessive GUCY2D mutation causing cone-rod dystrophy and not Leber's congenital amaurosis.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20517349","citation_count":20,"is_preprint":false},{"pmid":"35314386","id":"PMC_35314386","title":"The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.","date":"2022","source":"Ophthalmology. Retina","url":"https://pubmed.ncbi.nlm.nih.gov/35314386","citation_count":20,"is_preprint":false},{"pmid":"30319355","id":"PMC_30319355","title":"Photoreceptor Guanylate Cyclase (GUCY2D) Mutations Cause Retinal Dystrophies by Severe Malfunction of Ca2+-Dependent Cyclic GMP Synthesis.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30319355","citation_count":20,"is_preprint":false},{"pmid":"12325031","id":"PMC_12325031","title":"Evidence of a founder effect for the RETGC1 (GUCY2D) 2943DelG mutation in Leber congenital amaurosis pedigrees of Finnish origin.","date":"2002","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12325031","citation_count":20,"is_preprint":false},{"pmid":"24480840","id":"PMC_24480840","title":"A detailed phenotypic description of autosomal dominant cone dystrophy due to a de novo mutation in the GUCY2D gene.","date":"2014","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24480840","citation_count":19,"is_preprint":false},{"pmid":"22508049","id":"PMC_22508049","title":"S100B serves as a Ca(2+) sensor for ROS-GC1 guanylate cyclase in cones but not in rods of the murine retina.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22508049","citation_count":19,"is_preprint":false},{"pmid":"19056336","id":"PMC_19056336","title":"A tomato ER-type Ca2+-ATPase, LCA1, has a low thapsigargin-sensitivity and can transport manganese.","date":"2008","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/19056336","citation_count":18,"is_preprint":false},{"pmid":"15512997","id":"PMC_15512997","title":"A missense mutation in GUCY2D acts as a genetic modifier in RPE65-related Leber Congenital Amaurosis.","date":"2004","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15512997","citation_count":18,"is_preprint":false},{"pmid":"15175914","id":"PMC_15175914","title":"Autosomal dominant cone-rod dystrophy with R838H and R838C mutations in the GUCY2D gene in Japanese patients.","date":"2004","source":"Japanese journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/15175914","citation_count":18,"is_preprint":false},{"pmid":"15643614","id":"PMC_15643614","title":"A novel mutation in the GUCY2D gene responsible for an early onset severe RP different from the usual GUCY2D-LCA phenotype.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15643614","citation_count":18,"is_preprint":false},{"pmid":"33537894","id":"PMC_33537894","title":"Regulation of retinal membrane guanylyl cyclase (RetGC) by negative calcium feedback and RD3 protein.","date":"2021","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33537894","citation_count":17,"is_preprint":false},{"pmid":"23734073","id":"PMC_23734073","title":"A novel GUCY2D mutation in a Chinese family with dominant cone dystrophy.","date":"2013","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/23734073","citation_count":17,"is_preprint":false},{"pmid":"33109612","id":"PMC_33109612","title":"GUCY2D mutations in retinal guanylyl cyclase 1 provide biochemical reasons for dominant cone-rod dystrophy but not for stationary night blindness.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33109612","citation_count":16,"is_preprint":false},{"pmid":"28403437","id":"PMC_28403437","title":"Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/28403437","citation_count":16,"is_preprint":false},{"pmid":"11135490","id":"PMC_11135490","title":"Autosomal dominant cone-rod dystrophy due to a missense mutation (R838C) in the guanylate cyclase 2D gene (GUCY2D) with preserved rod function in one branch of the family.","date":"2000","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11135490","citation_count":16,"is_preprint":false},{"pmid":"15556616","id":"PMC_15556616","title":"S100B-modulated Ca2+-dependent ROS-GC1 transduction machinery in the gustatory epithelium: a new mechanism in gustatory transduction.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15556616","citation_count":16,"is_preprint":false},{"pmid":"22695961","id":"PMC_22695961","title":"A novel GUCY2D mutation, V933A, causes central areolar choroidal dystrophy.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22695961","citation_count":15,"is_preprint":false},{"pmid":"24875811","id":"PMC_24875811","title":"GUCY2D- or GUCA1A-related autosomal dominant cone-rod dystrophy: is there a phenotypic difference?","date":"2014","source":"Retina (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/24875811","citation_count":15,"is_preprint":false},{"pmid":"27475985","id":"PMC_27475985","title":"Novel GUCY2D mutation causes phenotypic variability of Leber congenital amaurosis in a large kindred.","date":"2016","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27475985","citation_count":14,"is_preprint":false},{"pmid":"26097748","id":"PMC_26097748","title":"Novel GUCY2D Gene Mutations in Japanese Male Twins with Leber Congenital Amaurosis.","date":"2015","source":"Journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/26097748","citation_count":14,"is_preprint":false},{"pmid":"18332321","id":"PMC_18332321","title":"New mutation, P575L, in the GUCY2D gene in a family with autosomal dominant progressive cone degeneration.","date":"2008","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/18332321","citation_count":14,"is_preprint":false},{"pmid":"33670772","id":"PMC_33670772","title":"Leber Congenital Amaurosis Due to GUCY2D Mutations: Longitudinal Analysis of Retinal Structure and Visual Function.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33670772","citation_count":13,"is_preprint":false},{"pmid":"9879655","id":"PMC_9879655","title":"Rod outer segment membrane guanylate cyclase type 1 (ROS-GC1) gene: structure, organization and regulation by phorbol ester, a protein kinase C activator.","date":"1998","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9879655","citation_count":13,"is_preprint":false},{"pmid":"26298565","id":"PMC_26298565","title":"GUCY2D mutations in a Chinese cohort with autosomal dominant cone or cone-rod dystrophies.","date":"2015","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/26298565","citation_count":12,"is_preprint":false},{"pmid":"17684531","id":"PMC_17684531","title":"Population history and infrequent mutations: how old is a rare mutation? GUCY2D as a worked example.","date":"2007","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/17684531","citation_count":11,"is_preprint":false},{"pmid":"23328348","id":"PMC_23328348","title":"Transgenic zebrafish expressing mutant human RETGC-1 exhibit aberrant cone and rod morphology.","date":"2013","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23328348","citation_count":10,"is_preprint":false},{"pmid":"26858600","id":"PMC_26858600","title":"Bicarbonate and Ca(2+) Sensing Modulators Activate Photoreceptor ROS-GC1 Synergistically.","date":"2016","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26858600","citation_count":9,"is_preprint":false},{"pmid":"22509151","id":"PMC_22509151","title":"Antithetical modes of and the Ca(2+) sensors targeting in ANF-RGC and ROS-GC1 membrane guanylate cyclases.","date":"2012","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22509151","citation_count":9,"is_preprint":false},{"pmid":"24808824","id":"PMC_24808824","title":"Ca(2+)-modulated ROS-GC1 transduction system in testes and its presence in the spermatogenic cells.","date":"2014","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24808824","citation_count":8,"is_preprint":false},{"pmid":"32811265","id":"PMC_32811265","title":"Variants at codon 838 in the GUCY2D gene result in different phenotypes of cone rod dystrophy.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32811265","citation_count":8,"is_preprint":false},{"pmid":"10394952","id":"PMC_10394952","title":"Alternative transcription initiation sites generate two LCA1 Ca2+-ATPase mRNA transcripts in tomato roots.","date":"1999","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10394952","citation_count":7,"is_preprint":false},{"pmid":"23686677","id":"PMC_23686677","title":"Phenotypic characterization of a Chinese family with autosomal dominant cone-rod dystrophy related to GUCY2D.","date":"2013","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/23686677","citation_count":7,"is_preprint":false},{"pmid":"26427419","id":"PMC_26427419","title":"A Mini-review: Animal Models of GUCY2D Leber Congenital Amaurosis (LCA1).","date":"2016","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26427419","citation_count":6,"is_preprint":false},{"pmid":"36654798","id":"PMC_36654798","title":"Preclinical studies in support of phase I/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis.","date":"2022","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/36654798","citation_count":6,"is_preprint":false},{"pmid":"36872573","id":"PMC_36872573","title":"Preliminary characterization of a novel form of progressive retinal atrophy in the German Spitz dog associated with a frameshift mutation in GUCY2D.","date":"2023","source":"Veterinary ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/36872573","citation_count":6,"is_preprint":false},{"pmid":"30588428","id":"PMC_30588428","title":"Long term follow-up of a family with GUCY2D dominant cone dystrophy.","date":"2018","source":"International journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/30588428","citation_count":6,"is_preprint":false},{"pmid":"19111294","id":"PMC_19111294","title":"Rod outer segment membrane guanylate cyclase type 1 (ROS-GC1) calcium-modulated transduction system in the sperm.","date":"2008","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/19111294","citation_count":5,"is_preprint":false},{"pmid":"34296052","id":"PMC_34296052","title":"Gucy2d selectively marks inhibitory dynorphin neurons in the spinal dorsal horn but is dispensable for pain and itch sensitivity.","date":"2021","source":"Pain reports","url":"https://pubmed.ncbi.nlm.nih.gov/34296052","citation_count":5,"is_preprint":false},{"pmid":"29427171","id":"PMC_29427171","title":"CO2/bicarbonate modulates cone photoreceptor ROS-GC1 and restores its CORD6-linked catalytic activity.","date":"2018","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29427171","citation_count":4,"is_preprint":false},{"pmid":"11952086","id":"PMC_11952086","title":"Calcium-sensitive ROS-GC1 signaling outside of photoreceptors: a common theme.","date":"2002","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11952086","citation_count":3,"is_preprint":false},{"pmid":"32255808","id":"PMC_32255808","title":"The pathogenicity of novel GUCY2D mutations in Leber congenital amaurosis 1 assessed by HPLC-MS/MS.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32255808","citation_count":3,"is_preprint":false},{"pmid":"34470921","id":"PMC_34470921","title":"Homozygosity mapping coupled with whole-exome sequencing and protein modelling identified a novel missense mutation in GUCY2D in a consanguineous Pakistani family with Leber congenital amaurosis.","date":"2021","source":"Journal of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34470921","citation_count":2,"is_preprint":false},{"pmid":"12596930","id":"PMC_12596930","title":"GCAPs: Ca2+-sensitive regulators of retGC.","date":"2002","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/12596930","citation_count":1,"is_preprint":false},{"pmid":"38483883","id":"PMC_38483883","title":"Development and characterization of a Gucy2d-cre mouse to selectively manipulate a subset of inhibitory spinal dorsal horn interneurons.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/38483883","citation_count":1,"is_preprint":false},{"pmid":"14674678","id":"PMC_14674678","title":"Structure and Ca2+ regulation of frog photoreceptor guanylate cyclase, ROS-GC1.","date":"2003","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14674678","citation_count":1,"is_preprint":false},{"pmid":"27881908","id":"PMC_27881908","title":"Functional study of two biochemically unusual mutations in GUCY2D Leber congenital amaurosis expressed via adenoassociated virus vector in mouse retinas.","date":"2016","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/27881908","citation_count":1,"is_preprint":false},{"pmid":"32009068","id":"PMC_32009068","title":"Novel GUCY2D Variant (E843Q) at Mutation Hotspot Associated with Macular Dystrophy in a Japanese Patient.","date":"2020","source":"Journal of Nippon Medical School = Nippon Ika Daigaku zasshi","url":"https://pubmed.ncbi.nlm.nih.gov/32009068","citation_count":1,"is_preprint":false},{"pmid":"39540020","id":"PMC_39540020","title":"Erratum: Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/39540020","citation_count":1,"is_preprint":false},{"pmid":"41012804","id":"PMC_41012804","title":"GUCY2D-Associated Retinopathy: A Comparative Study Between Humans and German Spitz Dogs.","date":"2025","source":"Veterinary sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41012804","citation_count":0,"is_preprint":false},{"pmid":"40688792","id":"PMC_40688792","title":"De novo variant in GUCY2D gene causing atypical cone-rod dystrophy in a consanguineous family and literature review.","date":"2025","source":"International journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/40688792","citation_count":0,"is_preprint":false},{"pmid":"36509996","id":"PMC_36509996","title":"Phenotypic characterization of autosomal dominant progressive cone dystrophies associated with a heterozygous variant c.2512C>T of GUCY2D gene in a large kindred.","date":"2022","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36509996","citation_count":0,"is_preprint":false},{"pmid":"41404193","id":"PMC_41404193","title":"A Novel GUCY2D Frameshift Deletion Identified in a Patient with Leber Congenital Amaurosis 1: A Case Report.","date":"2025","source":"Case reports in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/41404193","citation_count":0,"is_preprint":false},{"pmid":"42045071","id":"PMC_42045071","title":"Protein Inhibitor of Retinal Membrane Guanylyl Cyclase Rescues Mouse Rod Photoreceptors from GUCY2D Retinal Dystrophy.","date":"2026","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/42045071","citation_count":0,"is_preprint":false},{"pmid":"39100576","id":"PMC_39100576","title":"A GUCY2D variant associated cone-rod dystrophy with electronegative ERG: A case report and review.","date":"2024","source":"American journal of ophthalmology case reports","url":"https://pubmed.ncbi.nlm.nih.gov/39100576","citation_count":0,"is_preprint":false},{"pmid":"31470097","id":"PMC_31470097","title":"Possible dual contribution of a novel GUCY2D mutation in the development of retinal degeneration in a consanguineous population.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31470097","citation_count":0,"is_preprint":false},{"pmid":"31844802","id":"PMC_31844802","title":"A novel deletion mutation in GUCY2D gene may be responsible for Leber congenital amaurosis-1 disease: A case report.","date":"2019","source":"Journal of current ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31844802","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47144,"output_tokens":5435,"usd":0.111478},"stage2":{"model":"claude-opus-4-6","input_tokens":8993,"output_tokens":3024,"usd":0.180847},"total_usd":0.292325,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"RetGC-1 (GUCY2D) is a photoreceptor-specific membrane guanylyl cyclase whose recombinant form expressed in HEK293 cells has membrane GC activity that is stimulated by the activator p24 (GCAP) and inhibited by Ca2+ with an EC50 of 50-100 nM, establishing its core enzymatic properties and Ca2+ sensitivity.\",\n      \"method\": \"Recombinant expression in HEK293 cells, membrane GC activity assay, Ca2+ inhibition assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of enzymatic activity with quantitative Ca2+ sensitivity measurement\",\n      \"pmids\": [\"7777544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dominant cone-rod dystrophy (CORD6) is caused by missense mutations (E837D, R838C) in GUCY2D specifically in the dimerization domain, establishing GUCY2D as a causal gene for autosomal dominant retinal degeneration.\",\n      \"method\": \"Mutation screening by sequencing of GUCY2D in affected families; segregation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic linkage plus mutation identification replicated across multiple families and labs\",\n      \"pmids\": [\"9618177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The F514S mutation in ROS-GC1 (GUCY2D), linked to Leber congenital amaurosis (LCA1), severely damages intrinsic cyclase activity and inactivates the GCAP1-regulated CRM1 Ca2+ switch but does not affect the CRM2 switch, demonstrating domain-specific functional dissection of the two Ca2+ regulatory modules.\",\n      \"method\": \"In vitro mutagenesis, cGMP synthesis assay, Ca2+ sensitivity measurement in COS cell-expressed mutants\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with enzymatic assay and domain-specific functional readout\",\n      \"pmids\": [\"9888789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The R838C substitution in the RetGC-1 dimerization domain reduces overall catalytic ability, dramatically reduces stimulation by GCAP-2, increases apparent affinity for GCAP-1, and alters Ca2+ sensitivity of the GCAP-1 response, allowing mutant to be stimulated by GCAP-1 at higher Ca2+ concentrations than wild type — demonstrating a gain-of-function dominant mechanism.\",\n      \"method\": \"In vitro mutagenesis, cGMP synthesis assay, GCAP activation assays, Ca2+ sensitivity measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and multiple orthogonal assays\",\n      \"pmids\": [\"10430891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Two short regulatory regions (M445-L456 and L503-I522) in the juxtamembrane domain (JMD) of ROS-GC1 are critical for activation by GCAP-1, as identified by peptide competition and mutagenesis studies.\",\n      \"method\": \"Peptide competition assays, site-directed mutagenesis, GC activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis plus peptide competition with direct enzymatic readout\",\n      \"pmids\": [\"10571055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Neurocalcin is identified as a novel Ca2+-dependent activator of ROS-GC1 (GUCY2D), stimulating it in a dose-dependent fashion with EC50 ~20 µM Ca2+; the neurocalcin-regulated domain (CRM4) maps to the C-terminal segment (aa 731-1054) but is distinct from the CRM2 domain regulated by CD-GCAP.\",\n      \"method\": \"Recombinant protein assay, deletion mapping, GC activity assay, domain reconstruction\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with domain mapping via deletion mutants\",\n      \"pmids\": [\"10504230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD-GCAP differentially activates ROS-GC1 and ROS-GC2; the CD-GCAP-regulated stimulatory switch resides within amino acids 736-1053 of the cyclase, established by deletion, hybrid, and reconstruction expression studies.\",\n      \"method\": \"Deletion mutants, hybrid cyclase construction, heterologous expression, GC activity assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain mapping by multiple mutant constructs with direct enzymatic readout\",\n      \"pmids\": [\"9439621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"cGMP synthesis by RetGC-1 requires dimerization, and an intact alpha-helical coiled-coil structure in the dimerization domain is required for catalytic function; Arg838 within the dimerization domain establishes Ca2+ sensitivity of RetGC-1 by determining coiled-coil interaction strength. Arg838 substitutions dominantly enhance cGMP synthesis even at high Ca2+ and disrupt a salt bridge network as shown by molecular dynamics.\",\n      \"method\": \"In vitro mutagenesis, cGMP synthesis assay, Ca2+ sensitivity assay, molecular dynamics simulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, mutagenesis, and MD simulation providing mechanistic structural explanation\",\n      \"pmids\": [\"11306565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Complete abolition of retGC-1 catalytic activity (either by truncating mutations or by missense mutations in the catalytic domain) consistently leads to LCA; catalytic domain missense mutations abolish GTP-to-cGMP conversion in COS7 cells, while extracellular domain missense mutations mostly retain normal catalytic activity.\",\n      \"method\": \"In vitro mutagenesis, expression in COS7 cells, cGMP synthesis assay\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic in vitro functional analysis of 9 LCA-linked mutations with enzymatic assay\",\n      \"pmids\": [\"11328726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The Ca2+ sensitivity of RetGC-1 regulation by GCAP-1 is determined by both the affinity of GCAP-1 for Ca2+ and the relative affinities of the Ca2+-free vs. Ca2+-bound GCAP-1 for RetGC-1. The R838S CORD6 mutation increases the Ca2+ concentration required for half-maximal inhibition from 0.27 to 0.61 µM, primarily by changing the relative affinity of the mutant cyclase for Ca2+-free vs. Ca2+-loaded GCAP-1.\",\n      \"method\": \"Quantitative kinetic binding assay, Ca2+ sensitivity measurements, Mg2+-dependence analysis of recombinant RetGC-1\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro kinetic analysis with mutagenesis\",\n      \"pmids\": [\"15504042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LCA-linked catalytic domain mutations P858S and L954P in RetGC-1 severely impair basal and GCAP-1/GCAP-2-stimulated catalytic activity and act as dominant negative proteins when co-expressed with wild-type allele, reducing wild-type RetGC-1 activity. Extracellular domain mutations C105Y and L325P reduce GCAP-stimulated but not basal activity.\",\n      \"method\": \"In vitro mutagenesis, expression in HEK-293 cells, cGMP synthesis assay, co-expression dominant-negative assay\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with enzymatic activity and dominant-negative co-expression assay\",\n      \"pmids\": [\"15123990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RD3 protein is a high-affinity allosteric inhibitor of RetGC1 (GUCY2D), suppressing basal and GCAP-stimulated RetGC activity at submicromolar concentrations in a noncompetitive manner without significantly changing Ca2+ sensitivity; LCA12-associated RD3 truncation mutant fails to suppress RetGC1/GCAP complex, and several RD3 disease mutations decrease RD3 affinity for RetGC1.\",\n      \"method\": \"Recombinant protein expression in HEK293 cells, GC activity assay, mutagenesis, binding assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of allosteric inhibition with mutagenesis and binding characterization\",\n      \"pmids\": [\"21928830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ca2+-sensor protein S100B coexists with ROS-GC1 (GUCY2D) in cones but not rods of the murine retina, upregulates ROS-GC1 activity with K1/2 for Ca2+ >500 nM, and modulates neural signal transmission to cone ON-bipolar cells, as demonstrated by gene deletion models and single-cell recordings.\",\n      \"method\": \"Gene deletion mouse models, biochemistry, immunohistochemistry, ERG, single-cell recordings\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in intact retina including KO mouse, ERG, and single-cell recordings\",\n      \"pmids\": [\"22508049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The R838S mutation in RetGC1 causes CORD6 by deregulating Ca2+-sensitive feedback of phototransduction via GCAPs: transgenic mice expressing R838S RetGC1 show elevated dark cGMP, increased dark current, and altered rod photoresponses; photoreceptor degeneration is prevented in GCAP1,2-/- double knockout background, establishing GCAPs-mediated Ca2+ feedback as the primary trigger for degeneration.\",\n      \"method\": \"Transgenic mouse model, single-cell electrophysiology, ERG, genetic epistasis with GCAP KO\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — transgenic + genetic epistasis with physiological recordings, replicated across two mouse lines\",\n      \"pmids\": [\"29440533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Multiple GUCY2D mutations in the dimerization domain (E841K, K846N) shift Ca2+-sensitive regulation by GCAPs; the catalytic domain mutant P873R causes loss of function; and V902L causes a >20-fold increase in GC activity (constitutively active), showing distinct gain- and loss-of-function mechanisms depending on mutation location.\",\n      \"method\": \"Expression in HEK293 cells, GC activity assay, Ca2+ sensitivity assay, RD3 interaction assay\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic characterization of multiple mutants with Ca2+ regulation analysis\",\n      \"pmids\": [\"30319355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CSNB-linked mutations R666W, R761W, and L911F disable RetGC1 activation by GCAP1, -2, and -3; R666W and R761W additionally compromise GCAP1 binding in HEK293 cells; G982VfsX39 and L911F retain GCAP1 binding but fail to bind RD3; R768W fails to bind either GCAP1 or RD3. The CORD6 mutation R838S dominantly shifts Ca2+ sensitivity in the RetGC1 heterodimer (WT+R838S), requiring ~6-fold higher Ca2+ to decelerate cyclase compared to WT homodimer.\",\n      \"method\": \"In vitro mutagenesis, expression in HEK293 cells, GC activity assay, Ca2+ sensitivity measurement, co-immunoprecipitation binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic in vitro biochemical characterization with multiple mutants across disease classes\",\n      \"pmids\": [\"33109612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ROS-GC1 (GUCY2D) gene is composed of 20 exons and 19 introns spanning 18.5 kb, and the gene is induced by phorbol ester (protein kinase C activator), suggesting PKC-mediated transcriptional regulation of ROS-GC1 in photoreceptors.\",\n      \"method\": \"Gene structural analysis, luciferase reporter assay in COS cells, phorbol ester treatment\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gene structure determination plus reporter assay for PKC regulation\",\n      \"pmids\": [\"9879655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"S100B binds to domain amino acids Gly962-Asn981 of ROS-GC1 and signals through transduction domain aa Ile1030-Gln1041 to activate ROS-GC1 in gustatory epithelium, generating cGMP as a second messenger in gustatory transduction.\",\n      \"method\": \"Peptide competition, domain mutagenesis, GC activity assay, functional characterization in bovine gustatory epithelium\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — domain mapping by peptide competition and mutagenesis but in a non-retinal context\",\n      \"pmids\": [\"15556616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bicarbonate (generated from CO2 via carbonic anhydrase) directly targets the core catalytic domain of ROS-GC1 and activates it independently of Ca2+, synergizing with GCAP- and S100B-mediated Ca2+-dependent pathways; GCAP1 and GCAP2 signal through distinct domain-specific modules of ROS-GC1.\",\n      \"method\": \"Recombinant reconstitution, GC activity assay with bicarbonate, mutagenesis of LCA1-linked F514S mutant\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with direct enzymatic assay, but single lab\",\n      \"pmids\": [\"26858600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Expression of mutant human RETGC-1 (E837D/R838S) in zebrafish cone photoreceptors under the cone-specific gnat2 promoter causes aberrant cone morphology, reduced cone density, and reduced rod outer segment labeling, demonstrating that CORD6-linked GUCY2D mutations directly cause photoreceptor structural pathology in vivo.\",\n      \"method\": \"Transgenic zebrafish expression, fluorescent microscopy of retinal morphology, optokinetic response assay\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic in vivo model with retinal morphology and functional readout\",\n      \"pmids\": [\"23328348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The S248W GUCY2D mutation fails to restore rod and cone ERG function and shows marginal protein expression in photoreceptor outer segments in AAV-treated Gucy2e knockout mouse retinas, despite normal enzymatic activity in HEK293 cells, indicating that this mutation causes LCA1 by impairing protein expression, processing, or transport rather than catalytic activity.\",\n      \"method\": \"AAV-mediated expression in Gucy2e KO mouse retinas, ERG, immunofluorescence, immunoblot, GC activity assay\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo AAV expression in KO mouse with multiple readouts contrasted with in vitro data\",\n      \"pmids\": [\"27881908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"An engineered protein inhibitor of retinal guanylyl cyclase (PIGCY) expressed in transgenic GUCY2D adCORD (R838S) mice suppresses aberrant cGMP production, prevents rod photoreceptor degeneration (70% of nuclei preserved vs. 20% in R838S alone at 6 months), and maintains functional light sensitivity, demonstrating that reducing cGMP synthesis is sufficient to rescue degenerating GUCY2D adCORD rods.\",\n      \"method\": \"Transgenic mouse model, ERG, single-photon response recording, photoreceptor nuclei counting, GC activity measurement\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo genetic rescue with functional and structural endpoints, multiple orthogonal readouts\",\n      \"pmids\": [\"42045071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Gucy2d is selectively expressed in dynorphin-lineage inhibitory neurons in laminae I-III of the adult mouse spinal dorsal horn but not in the brain or DRG; Gucy2d knockout mice show no altered responses to itch or pain, indicating the protein is dispensable for these sensory functions in spinal cord.\",\n      \"method\": \"In situ hybridization, Gucy2d knockout mouse behavioral assays (pain, itch)\",\n      \"journal\": \"Pain reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined behavioral readout and localization by ISH, but non-retinal context\",\n      \"pmids\": [\"34296052\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GUCY2D encodes retinal membrane guanylyl cyclase 1 (RetGC1/ROS-GC1), a photoreceptor-specific enzyme that synthesizes cGMP from GTP; its catalytic activity requires homodimerization via a coiled-coil dimerization domain, is stimulated at low Ca2+ by GCAP1 and GCAP2 binding to distinct juxtamembrane and C-terminal regulatory modules, is inhibited at high Ca2+ through the same GCAPs, is additionally modulated by neurocalcin, S100B, CD-GCAP, bicarbonate, and by RD3 protein (a high-affinity allosteric inhibitor); dominant CORD6-causing mutations at Arg838 in the dimerization domain shift Ca2+ sensitivity of GCAP-mediated regulation, causing constitutive cGMP overproduction in the dark that elevates free Ca2+ and triggers photoreceptor degeneration through a phototransduction feedback mechanism, while recessive LCA1-causing mutations abolish catalytic activity or impair GCAP binding/RD3 binding, leading to insufficient cGMP synthesis and failure of phototransduction recovery.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GUCY2D encodes retinal guanylyl cyclase 1 (RetGC1/ROS-GC1), a photoreceptor-specific membrane guanylyl cyclase that synthesizes cGMP from GTP and is essential for phototransduction recovery. Its catalytic activity requires homodimerization via an α-helical coiled-coil dimerization domain and is stimulated at low Ca²⁺ by guanylyl cyclase-activating proteins (GCAP1 and GCAP2) binding to distinct juxtamembrane and C-terminal regulatory modules, with additional modulation by neurocalcin, S100B, RD3 (a high-affinity allosteric inhibitor), and bicarbonate [PMID:7777544, PMID:10504230, PMID:21928830, PMID:26858600]. Recessive loss-of-function mutations in the catalytic domain cause Leber congenital amaurosis type 1 (LCA1) by abolishing cGMP synthesis, whereas dominant gain-of-function mutations at Arg838 in the dimerization domain cause cone-rod dystrophy (CORD6) by shifting GCAP-mediated Ca²⁺-sensitive feedback so that cGMP overproduction persists at elevated Ca²⁺, triggering photoreceptor degeneration through a GCAP-dependent mechanism [PMID:9618177, PMID:11328726, PMID:29440533, PMID:33109612]. Suppression of aberrant cGMP production by an engineered inhibitor rescues photoreceptor degeneration in a CORD6 mouse model, confirming that dysregulated cyclase output is the proximal cause of disease [PMID:42045071].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing RetGC1 as a Ca²⁺-sensitive guanylyl cyclase answered the question of which enzyme regenerates cGMP in photoreceptors and how phototransduction feedback operates at the enzymatic level.\",\n      \"evidence\": \"Recombinant RetGC-1 expressed in HEK293 cells showed membrane GC activity stimulated by GCAP and inhibited by Ca²⁺ with EC50 ~50–100 nM\",\n      \"pmids\": [\"7777544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the cyclase\", \"Stoichiometry and binding mode of GCAP interaction unknown\", \"In vivo validation of Ca²⁺ sensitivity parameters not yet performed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of CORD6-causing mutations (E837D, R838C) in the dimerization domain and mapping of CD-GCAP and GCAP1 regulatory regions defined both the disease relevance and modular regulatory architecture of RetGC1.\",\n      \"evidence\": \"Genetic linkage and sequencing in affected families identified dimerization-domain mutations; deletion/hybrid cyclase constructs mapped CD-GCAP signaling to aa 736–1053 and GCAP1 regulation to juxtamembrane residues M445–L456 and L503–I522\",\n      \"pmids\": [\"9618177\", \"9439621\", \"10571055\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which dimerization domain mutations cause dominant disease not yet biochemically resolved\", \"Relationship between GCAP1 and CD-GCAP regulatory modules unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"In vitro reconstitution of CORD6 (R838C) and LCA1 (F514S) mutations revealed that disease arises through fundamentally different mechanisms — gain-of-function Ca²⁺-sensitivity shift versus loss of catalytic activity — answering how the same gene causes dominant and recessive disease.\",\n      \"evidence\": \"R838C increased apparent GCAP-1 affinity and allowed cyclase stimulation at elevated Ca²⁺; F514S abolished intrinsic cyclase activity and CRM1 but not CRM2 regulation; neurocalcin identified as a distinct Ca²⁺-dependent activator acting through CRM4\",\n      \"pmids\": [\"10430891\", \"9888789\", \"10504230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation of gain-of-function mechanism not yet obtained\", \"Physiological relevance of neurocalcin regulation to photoreceptor function unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that RetGC1 functions as a dimer whose coiled-coil integrity determines both catalytic competence and Ca²⁺ sensitivity established the structural basis for Arg838 dominant mutations.\",\n      \"evidence\": \"Mutagenesis and molecular dynamics showed that Arg838 substitutions disrupt a salt-bridge network in the dimerization domain, enabling cGMP synthesis even at high Ca²⁺; catalytic-domain LCA mutations abolish GTP-to-cGMP conversion\",\n      \"pmids\": [\"11306565\", \"11328726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of the dimerization domain\", \"How dimer interface perturbation propagates to catalytic domain activation unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantitative kinetic analysis revealed that CORD6 mutations shift Ca²⁺ sensitivity by altering the relative affinity of Ca²⁺-free versus Ca²⁺-bound GCAP1 for RetGC1, and that some LCA mutations act as dominant negatives through heterodimer poisoning.\",\n      \"evidence\": \"R838S raised the Ca²⁺ IC50 from 0.27 to 0.61 µM by changing GCAP1 binding equilibria; P858S and L954P reduced wild-type activity in co-expression assays; S100B mapped to Gly962–Asn981 in gustatory epithelium\",\n      \"pmids\": [\"15504042\", \"15123990\", \"15556616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dominant-negative mechanism not validated in photoreceptor models\", \"Physiological relevance of S100B regulation in taste versus retina unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of RD3 as a high-affinity allosteric inhibitor of RetGC1 revealed a second layer of cyclase regulation beyond GCAPs and explained LCA12 pathogenesis.\",\n      \"evidence\": \"Recombinant RD3 suppressed basal and GCAP-stimulated RetGC1 activity at submicromolar concentrations noncompetitively; LCA12 truncation mutant lost inhibitory function\",\n      \"pmids\": [\"21928830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RD3 binding site on RetGC1 not mapped\", \"In vivo dynamics of RD3-RetGC1 interaction in outer segments unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that bicarbonate directly activates the RetGC1 catalytic domain independently of Ca²⁺ added a metabolic regulatory input to phototransduction, and in vivo testing showed that the S248W LCA1 mutation impairs protein trafficking rather than catalysis.\",\n      \"evidence\": \"Bicarbonate activated recombinant RetGC1 synergistically with GCAP pathways; S248W showed normal HEK293 activity but failed to reach outer segments or restore ERG in AAV-treated Gucy2e KO mice\",\n      \"pmids\": [\"26858600\", \"27881908\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Bicarbonate regulation not confirmed in intact photoreceptors\", \"Trafficking mechanism of RetGC1 to outer segments not elucidated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Genetic epistasis in transgenic mice proved that CORD6 photoreceptor degeneration is driven through GCAP-mediated Ca²⁺ feedback rather than cyclase-intrinsic toxicity, resolving the in vivo pathogenic mechanism.\",\n      \"evidence\": \"R838S transgenic mice showed elevated dark cGMP and degeneration prevented in GCAP1,2 double-knockout background; additional dimerization-domain mutants (E841K, K846N) confirmed shifted Ca²⁺ regulation while V902L showed constitutive activation\",\n      \"pmids\": [\"29440533\", \"30319355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cone-specific degeneration mechanism not fully characterized in vivo\", \"Whether constitutively active mutants also require GCAPs for toxicity unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic analysis of CSNB-linked mutations showed that loss of GCAP binding and/or RD3 binding represent separable disease mechanisms, and that R838S dominantly shifts Ca²⁺ sensitivity even in WT/mutant heterodimers.\",\n      \"evidence\": \"R666W and R761W lost GCAP1 binding; G982VfsX39 and L911F lost RD3 binding; WT+R838S heterodimer required ~6-fold more Ca²⁺ for deceleration versus WT homodimer\",\n      \"pmids\": [\"33109612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterodimer structure not resolved\", \"Relative abundance of WT vs mutant allele in heterozygous photoreceptors unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Therapeutic rescue demonstrated that reducing aberrant cGMP production is sufficient to prevent CORD6 degeneration, validating cyclase output as the druggable node in dominant GUCY2D disease.\",\n      \"evidence\": \"Engineered protein inhibitor (PIGCY) in R838S transgenic mice preserved 70% photoreceptor nuclei at 6 months and maintained light sensitivity by ERG and single-photon recordings\",\n      \"pmids\": [\"42045071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term durability of PIGCY-mediated rescue not established\", \"Cone rescue not demonstrated\", \"Optimal level of cyclase inhibition for clinical translation unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"High-resolution structural models of full-length RetGC1 dimers, the precise binding interfaces for GCAPs and RD3, and the mechanism by which bicarbonate and metabolic signals integrate with Ca²⁺-dependent regulation in intact photoreceptors remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or crystal structure of RetGC1 homodimer\", \"GCAP and RD3 binding interfaces not structurally resolved\", \"Cone-specific regulatory mechanisms poorly characterized in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": [0, 2, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 13, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 9, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 8, 13]}\n    ],\n    \"complexes\": [\n      \"RetGC1 homodimer\"\n    ],\n    \"partners\": [\n      \"GUCA1A\",\n      \"GUCA1B\",\n      \"RD3\",\n      \"S100B\",\n      \"VILIP3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}